The ultrasound group of Siemens Medical Systems will roll outa new line of scanners designed to establish the division as amajor player in the ultrasound market. The line includes the long-awaitedSonoline Elegra premium scanner (SCAN 4/26/95). Elegra is
The ultrasound group of Siemens Medical Systems will roll outa new line of scanners designed to establish the division as amajor player in the ultrasound market. The line includes the long-awaitedSonoline Elegra premium scanner (SCAN 4/26/95).
Elegra is based on digital beamformer technology and employs128 channels, according to Lothar Koob, vice president of theultrasound group. Siemens has developed synthetic aperture softwaretechniques that enable Elegra to perform as though it has 256channels, Koob said. The scanner's output will be DICOM-compliantwithout the need for an interface box. Siemens has applied forFood and Drug Administration clearance for Elegra.
Sonoline Prima is an entry-level gray-scale scanner that replacesthe Sonoline 250, 400 and 450 scanners. Both Elegra and Primacomplement the mid-range Sonoline Versa system introduced lastyear (SCAN 11/23/94).
The nuclear medicine group of Siemens will display several newtechnologies targeted at reestablishing the vendor's leadershipin the modality. The group will feature the open-architectureDiacam and MultiSPECT cameras, as well as its digital detectortechnology and Mµsic simultaneous attenuation correctionprotocol.
In digital image management, Siemens will concentrate on alliancesestablished with other Siemens groups that specialize in telecommunicationstechnology. The PACS group is working with Siemens Rolm, a networkservices company that has a wireless phone that can be used toset up a private phone network in a hospital. Another Siemensgroup, Siemens Systems Integration, has experience designing LANand WAN systems.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
What New Research Reveals About ChatGPT and Ultrasound Detection of Thyroid Nodules
March 13th 2024In a comparison of image-to-text large language models (LLMs), ChatGPT 4.0 offered a 95 percent sensitivity rate and an 83 percent AUC that were comparable to that of two senior radiologists and one junior radiologist interacting with LLM to differentiate between malignant and benign thyroid nodules on ultrasound.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.